Home » Posts tagged with » C3 glomerulopathy
Apellis reports positive results for pegcetacoplan in phase 2 C3G trial
Apellis Pharmaceuticals has reported positive results for pegcetacoplan from the phase 2 DISCOVERY clinical trial in patients with C3 glomerulopathy (C3G), a type of kidney disease. According to the US biopharma company, the 48-week results demonstrated that patients subjected to pegcetacoplan had sustained improvements across key clinical measures. These include a greater than 65% mean […]
Business News Today
- Lendesk acquires digital mortgage origination provider Finmo Financial
- B&G Foods to acquire Crisco shortening brand from Smucker’s for $550m
- Carlyle Group acquires 27 distribution logistics assets in France and Germany
- LubeZone acquires mobile truck services provider All Star Truck Repair
- Diageo to acquire Chase Original Potato Vodka owner Chase Distillery
- Coca-Cola European Partners plans to acquire Coca-Cola Amatil for $6.6bn
- Verisem acquires new vegetable seed processing facility in Warden, WA
- GrubMarket acquires Los Angeles-based produce provider Best Fresh Produce
- Danone’s Nutricia acquires special needs business Real Food Blends
- Bluestar Alliance wins stalking horse bid for tween fashion brand Justice
